Fisher Asset Management’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-450,795
Closed -$7.15M 1147
2023
Q3
$7.15M Sell
450,795
-252,122
-36% -$4.19M ﹤0.01% 475
2023
Q2
$13.3M Sell
702,917
-151,820
-18% -$1.79M 0.01% 420
2023
Q1
$3.28M Buy
854,737
+2,705
+0.3% +$11.5K ﹤0.01% 593
2022
Q4
$4.23M Buy
852,032
+267,257
+46% +$1.45M ﹤0.01% 551
2022
Q3
$2.79M Buy
584,775
+203,569
+53% +$1.07M ﹤0.01% 521
2022
Q2
$1.72M Buy
381,206
+722
+0.2% +$3.14K ﹤0.01% 550
2022
Q1
$1.81M Buy
380,484
+144,503
+61% +$800K ﹤0.01% 563
2021
Q4
$1.75M Buy
235,981
+151,183
+178% +$940K ﹤0.01% 577
2021
Q3
$481K Sell
84,798
-271
-0.3% -$1.57K ﹤0.01% 733
2021
Q2
$561K Buy
85,069
+43,127
+103% +$301K ﹤0.01% 698
2021
Q1
$340K Buy
41,942
+1,487
+4% +$12.1K ﹤0.01% 765
2020
Q4
$261K Sell
40,455
-1,000
-2% -$5.83K ﹤0.01% 819
2020
Q3
$149K Buy
41,455
+992
+2% +$4K ﹤0.01% 819
2020
Q2
$186K Sell
40,463
-1,023
-2% -$4.35K ﹤0.01% 781
2020
Q1
$141K Buy
41,486
+1,050
+3% +$4.59K ﹤0.01% 743
2019
Q4
$206K Sell
40,436
-122,795
-75% -$417K ﹤0.01% 788
2019
Q3
$395K Sell
163,231
-237
-0.1% -$629 ﹤0.01% 712
2019
Q2
$355K Buy
163,468
+26,397
+19% +$62.4K ﹤0.01% 714
2019
Q1
$371K Sell
137,071
-1,146
-0.8% -$4.96K ﹤0.01% 682
2018
Q4
$663K Buy
138,217
+1,268
+0.9% +$7.69K ﹤0.01% 628
2018
Q3
$1.3M Buy
136,949
+141
+0.1% +$1.35K ﹤0.01% 565
2018
Q2
$1.33M Sell
136,808
-117
-0.1% -$1.23K ﹤0.01% 557
2018
Q1
$1.44M Sell
136,925
-21,551
-14% -$213K ﹤0.01% 544
2017
Q4
$1.02M Sell
158,476
-90,100
-36% -$556K ﹤0.01% 580
2017
Q3
$1.9M Sell
248,576
-7,630
-3% -$50.7K ﹤0.01% 508
2017
Q2
$1.82M Buy
256,206
+2,530
+1% +$11.6K ﹤0.01% 488
2017
Q1
$982K Buy
253,676
+5,100
+2% +$14.9K ﹤0.01% 510
2016
Q4
$507K Sell
248,576
-5,125
-2% -$10.3K ﹤0.01% 563
2016
Q3
$680K Hold
253,701
﹤0.01% 541
2016
Q2
$751K Buy
253,701
+9,476
+4% +$59.4K ﹤0.01% 533
2016
Q1
$2.24M Buy
+244,225
New +$2.07M ﹤0.01% 457

Other funds holding IMGN